Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Inventory (2019 - 2025)

Pulmonx (LUNG) has disclosed Change in Inventory for 7 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • Quarterly Change in Inventory rose 271.31% to $1.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $108000.0 through Sep 2025, up 108.48% year-over-year, with the annual reading at $229000.0 for FY2024, 124.95% up from the prior year.
  • Change in Inventory for Q3 2025 was $1.0 million at Pulmonx, up from -$660000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $2.0 million in Q1 2022, with the low at -$1.3 million in Q4 2023.
  • Average Change in Inventory over 5 years is $492736.8, with a median of $604000.0 recorded in 2023.
  • The sharpest move saw Change in Inventory tumbled 463.41% in 2024, then surged 271.31% in 2025.
  • Over 5 years, Change in Inventory stood at $1.5 million in 2021, then plummeted by 136.91% to -$536000.0 in 2022, then crashed by 151.68% to -$1.3 million in 2023, then surged by 111.34% to $153000.0 in 2024, then skyrocketed by 567.32% to $1.0 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $1.0 million, -$660000.0, and -$406000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.